Open Access

High expression level of peptidylprolyl isomerase A is correlated with poor prognosis of liver hepatocellular carcinoma

  • Authors:
    • Shilong Wang
    • Minghuan Li
    • Ligang Xing
    • Jinming Yu
  • View Affiliations

  • Published online on: September 10, 2019     https://doi.org/10.3892/ol.2019.10846
  • Pages: 4691-4702
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Peptidylprolyl isomerase A (PPIA) has been reported to be correlated with cancer. The present study investigated the prognostic values of PPIA expression levels in cancer by comparing different types of cancer using databases. High expression levels of PPIA were observed in 17 out of 17 cancer types compared with normal adjacent tissues. High expression levels of PPIA were associated with decreased overall survival in low grade glioma, acute myeloid leukemia, lung adenocarcinoma, skin cutaneous melanoma and liver hepatocellular carcinoma (LIHC). The prognostic effect of PPIA expression in LIHC was independent of tumor grade. High expression levels of PPIA were of particular prognostic value in stage 3, American Joint Committee on Cancer Tumor 3, hepatitis B virus negative and sorafenib‑administered subgroups in LIHC. The expression level of PPIA was significantly associated with levels of basigin and signal transducer and activator of transcription 3, which may be major effectors of PPIA in the progression of the cancer.
View Figures
View References

Related Articles

Journal Cover

November-2019
Volume 18 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang S, Li M, Xing L and Yu J: High expression level of peptidylprolyl isomerase A is correlated with poor prognosis of liver hepatocellular carcinoma . Oncol Lett 18: 4691-4702, 2019.
APA
Wang, S., Li, M., Xing, L., & Yu, J. (2019). High expression level of peptidylprolyl isomerase A is correlated with poor prognosis of liver hepatocellular carcinoma . Oncology Letters, 18, 4691-4702. https://doi.org/10.3892/ol.2019.10846
MLA
Wang, S., Li, M., Xing, L., Yu, J."High expression level of peptidylprolyl isomerase A is correlated with poor prognosis of liver hepatocellular carcinoma ". Oncology Letters 18.5 (2019): 4691-4702.
Chicago
Wang, S., Li, M., Xing, L., Yu, J."High expression level of peptidylprolyl isomerase A is correlated with poor prognosis of liver hepatocellular carcinoma ". Oncology Letters 18, no. 5 (2019): 4691-4702. https://doi.org/10.3892/ol.2019.10846